🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
In this study, breast cancer (BC) patients eligible for inclusion will be d...
Status
Completed
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2024-12-23
Trial ID
NCT06636591
RATIONALE: Patients with HER2-negative advanced breast cancer have limited ...
Status
Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2023-08-01
Trial ID
NCT05981001
This study aims to compare the efficacy and safety of short-course definiti...
Status
Recruiting
Location
Jiangsu Cancer Hospital /Jiangsu Institute of Cancer Research
Start Date
2025-12-01
Trial ID
NCT07530094
Treatments Being Tested
This prospective, single-arm, multicenter, phase II trial enrolled 40 patie...
Status
Unknown
Location
Sun Yat-Sen Memorial Hospital of Sun Yat-sen University
Start Date
2020-08-01
Trial ID
NCT04541251
Treatments Being Tested
This study is a randomized, double-blind, placebo-controlled, multi-center ...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2021-05-28
Trial ID
NCT04768075
Treatments Being Tested
This is a multi-center, Phase II clinical study aiming to evaluate the effi...
Status
Recruiting
Location
Tianjin Cancer Hospital
Start Date
2025-11-03
Trial ID
NCT07162506
Treatments Being Tested
Esophageal squamous cell carcinoma (ESCC) is highly prevalent in China, wit...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-20
Trial ID
NCT07778056
Treatments Being Tested
This study aims to evaluate the efficacy and safety of neoadjuvant camreliz...
Status
Recruiting
Location
Shandong Cancer Hospital and Institute
Start Date
2022-12-02
Trial ID
NCT06241807
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of Camreli...
Status
Unknown
Location
Wuhan Union Hospital
Start Date
2021-08-20
Trial ID
NCT04943029